Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these https://lewiswhsh591626.ampedpages.com/tirzepatide-a-promising-new-treatment-for-obesity-63116367